Many readers of The Cancer Letter will have seen or at least be aware of the buzz surrounding release of the new “Oppenheimer” movie, which has received excellent reviews.
As a community, we strive for cancer treatment and research that is data-driven, patient-centered, and that meets the highest standards of quality and safety. Yet, as physicians and advocates, we’ve become aware of a situation where these ambitions are not being met.